ASSOCIATION BETWEEN URINARY BISPHENOL A CONCENTRATION AND OBESITY PREVALENCE IN CHILDREN AND ADOLESCENTS Leonardo Trasande, MD, MPP Teresa Attina, MD,
Cholesterol Metabolism and Homeostasis. 2 Basic Lipoprotein Structure Phospholipid (phosphatidylethanolamine, phosphatidylcholine, phosphatidylserine,
New Concepts in the Evaluation and Treatment of Dyslipidemia Nathan D. Wong, PhD, FACC Professor and Director Heart Disease Prevention Program Division.
UPDATE ON THE PCKS9 INHIBITION TO LOWER LDL CHOLESTEROL
It’s all relative: Genetic dyslipidaemia. CVD risk factors, and especially lipid metabolism, exemplify gene / environment interactions Mainly genetic.
New Insights in the Understanding of Cholesterol Metabolism: The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Regulation of Low-Density.
Genetic Variants of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Implications for Low-Density Lipoprotein Cholesterol (LDL-C) © 2014 Amgen Inc.
Infusion MS/MS ALL Workflow; TripleTOF™ 5600 System for Lipid Analysis Brigitte Simons, Sr. Applications and Sales Specialist at AB SCIEX.
Increased Cardiovascular Risk with Pain-relieving Coxib Medications: Disruption of Cholesterol Metabolism Increased Cardiovascular Risk with Pain-relieving.
Gender, Nutrigenomics and CVD Jose M Ordovas, PHD Director, Nutrition and Genomics Laboratory Jean Mayer USDA Human Nutrition Research Center on Aging.
Increased Cardiovascular Risk with Pain-relieving Coxib
The State of Dyslipidemia Treatment USA-145-101385 © 2014 Amgen Inc. All rights reserved. Not for Reproduction.
